Drug information for METROCREAM

Form Dosage Status Therapeutic Equivalence Active Ingred Ref. Sponsor Document
CREAM; TOPICAL 0.75% Prescription AB (Reference Drug) METRONIDAZOLE Metronidazole GALDERMA LABS LP 20531

Drug Adverse Effects information for METROCREAM

Role code Indications Reaction # Reports
C ABDOMINAL PAIN ALANINE AMINOTRANSFERASE INCREASED 1
C ABDOMINAL PAIN ASPARTATE AMINOTRANSFERASE INCREASED 1
C ABDOMINAL PAIN BLOOD LACTATE DEHYDROGENASE INCREASED 1
C ABDOMINAL PAIN HEPATOTOXICITY 1
C ABDOMINAL PAIN METASTASES TO LIVER 1
C ACNE ADENOMA BENIGN 14
C ACNE ADNEXA UTERI MASS 14
C ACNE BACK PAIN 14
C ACNE COLITIS 14
C ACNE COLITIS ULCERATIVE 14
C ACNE CROHN'S DISEASE 14
C ACNE DEPRESSION 14
C ACNE DRY SKIN 14
C ACNE GASTROINTESTINAL DISORDER 14
C ACNE HEPATIC CYST 14
C ACNE INFLAMMATORY BOWEL DISEASE 14
C ACNE IRRITABLE BOWEL SYNDROME 14
C ACNE MOUTH CYST 14
C ACNE MYALGIA 14
C ACNE MYOSITIS 14
C ACNE OVARIAN CYST 14
C ACNE PAIN 14
C ACNE PROCTITIS 14
C ACNE ROAD TRAFFIC ACCIDENT 14
C ACNE SCOLIOSIS 14
C ACNE CYSTIC ADENOMA BENIGN 2
C ACNE CYSTIC ADNEXA UTERI MASS 2
C ACNE CYSTIC BACK PAIN 2
C ACNE CYSTIC COLITIS 2
C ACNE CYSTIC COLITIS ULCERATIVE 2
C ACNE CYSTIC CROHN'S DISEASE 2
C ACNE CYSTIC DEPRESSION 2
C ACNE CYSTIC DRY SKIN 2
C ACNE CYSTIC GASTROINTESTINAL DISORDER 2
C ACNE CYSTIC HEPATIC CYST 2
C ACNE CYSTIC INFLAMMATORY BOWEL DISEASE 2
C ACNE CYSTIC IRRITABLE BOWEL SYNDROME 2
C ACNE CYSTIC MOUTH CYST 2
C ACNE CYSTIC MYALGIA 2
C ACNE CYSTIC MYOSITIS 2
C ACNE CYSTIC OVARIAN CYST 2
C ACNE CYSTIC PAIN 2
C ACNE CYSTIC PROCTITIS 2
C ACNE CYSTIC ROAD TRAFFIC ACCIDENT 2
C ACNE CYSTIC SCOLIOSIS 2
C CONTRACEPTION ADENOMA BENIGN 2
C CONTRACEPTION ADNEXA UTERI MASS 2
C CONTRACEPTION BACK PAIN 2
C CONTRACEPTION COLITIS 2
C CONTRACEPTION COLITIS ULCERATIVE 2
C CONTRACEPTION CROHN'S DISEASE 2
C CONTRACEPTION DEPRESSION 2
C CONTRACEPTION DRY SKIN 2
C CONTRACEPTION GASTROINTESTINAL DISORDER 2
C CONTRACEPTION HEPATIC CYST 2
C CONTRACEPTION INFLAMMATORY BOWEL DISEASE 2
C CONTRACEPTION IRRITABLE BOWEL SYNDROME 2
C CONTRACEPTION MOUTH CYST 2
C CONTRACEPTION MYALGIA 2
C CONTRACEPTION MYOSITIS 2
C CONTRACEPTION OVARIAN CYST 2
C CONTRACEPTION PAIN 2
C CONTRACEPTION PROCTITIS 2
C CONTRACEPTION ROAD TRAFFIC ACCIDENT 2
C CONTRACEPTION SCOLIOSIS 2
C CRYOPYRIN ASSOCIATED PERIODIC SYNDROME CHEST PAIN 2
C DIABETES MELLITUS DIABETIC KETOACIDOSIS 1
C DIABETES MELLITUS HYPERGLYCAEMIA 1
C DIABETES MELLITUS HYPERSENSITIVITY 1
C DIABETES MELLITUS NAUSEA 1
C DIABETES MELLITUS PRURITUS 1
C DIABETES MELLITUS URINARY TRACT INFECTION 1
C DIABETES MELLITUS VIRAL INFECTION 1
C DYSPNOEA BONE PAIN 2
C DYSPNOEA CARDIAC FAILURE 1
C DYSPNOEA CHRONIC OBSTRUCTIVE PULMONARY DISEASE 2
C DYSPNOEA CORONARY ARTERY DISEASE 2
C DYSPNOEA INJECTION SITE HAEMATOMA 2
C DYSPNOEA MUSCLE SPASMS 2
C DYSPNOEA NAUSEA 1
C DYSPNOEA OEDEMA PERIPHERAL 2
C DYSPNOEA PAIN 1
C DYSPNOEA UNRESPONSIVE TO STIMULI 2
C DYSPNOEA VISUAL IMPAIRMENT 2
C FOLLICULITIS ALANINE AMINOTRANSFERASE INCREASED 2
C FOLLICULITIS ASPARTATE AMINOTRANSFERASE INCREASED 2
C FOLLICULITIS BLOOD LACTATE DEHYDROGENASE INCREASED 2
C FOLLICULITIS HEPATOTOXICITY 2
C FOLLICULITIS METASTASES TO LIVER 2
C HYPERTENSION DIABETIC KETOACIDOSIS 2
C HYPERTENSION HYPERGLYCAEMIA 2
C HYPERTENSION HYPERSENSITIVITY 2
C HYPERTENSION NAUSEA 2
C HYPERTENSION PRURITUS 2
C HYPERTENSION URINARY TRACT INFECTION 2
C HYPERTENSION VIRAL INFECTION 2
C HYPOTHYROIDISM DIABETIC KETOACIDOSIS 1
C HYPOTHYROIDISM HYPERGLYCAEMIA 1
C HYPOTHYROIDISM HYPERSENSITIVITY 1
C HYPOTHYROIDISM NAUSEA 1
C HYPOTHYROIDISM PRURITUS 1
C HYPOTHYROIDISM URINARY TRACT INFECTION 1
C HYPOTHYROIDISM VIRAL INFECTION 1
C NON-SMALL CELL LUNG CANCER ALANINE AMINOTRANSFERASE INCREASED 1
C NON-SMALL CELL LUNG CANCER ASPARTATE AMINOTRANSFERASE INCREASED 1
C NON-SMALL CELL LUNG CANCER BLOOD LACTATE DEHYDROGENASE INCREASED 1
C NON-SMALL CELL LUNG CANCER HEPATOTOXICITY 1
C NON-SMALL CELL LUNG CANCER METASTASES TO LIVER 1
C OSTEOPOROSIS BONE PAIN 2
C OSTEOPOROSIS CARDIAC FAILURE 1
C OSTEOPOROSIS CHRONIC OBSTRUCTIVE PULMONARY DISEASE 2
C OSTEOPOROSIS CORONARY ARTERY DISEASE 2
C OSTEOPOROSIS INJECTION SITE HAEMATOMA 2
C OSTEOPOROSIS MUSCLE SPASMS 2
C OSTEOPOROSIS NAUSEA 1
C OSTEOPOROSIS OEDEMA PERIPHERAL 2
C OSTEOPOROSIS PAIN 1
C OSTEOPOROSIS UNRESPONSIVE TO STIMULI 2
C OSTEOPOROSIS VISUAL IMPAIRMENT 2
C RASH BONE PAIN 2
C RASH CARDIAC FAILURE 1
C RASH CHRONIC OBSTRUCTIVE PULMONARY DISEASE 2
C RASH CORONARY ARTERY DISEASE 2
C RASH INJECTION SITE HAEMATOMA 2
C RASH MUSCLE SPASMS 2
C RASH NAUSEA 1
C RASH OEDEMA PERIPHERAL 2
C RASH PAIN 1
C RASH UNRESPONSIVE TO STIMULI 2
C RASH VISUAL IMPAIRMENT 2
C TUMOUR PAIN ALANINE AMINOTRANSFERASE INCREASED 1
C TUMOUR PAIN ASPARTATE AMINOTRANSFERASE INCREASED 1
C TUMOUR PAIN BLOOD LACTATE DEHYDROGENASE INCREASED 1
C TUMOUR PAIN HEPATOTOXICITY 1
C TUMOUR PAIN METASTASES TO LIVER 1
Ads by Google